Research and Markets: Brain Cancer Therapeutics Pipeline Review, H1 2015 - Analysis of 37 Companies & 60 Drug Profiles

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/z36pzl/brain_cancer) has announced the addition of the "Brain Cancer - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Brain Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • AbbVie Inc.
  • AngioChem Inc.
  • Arrien Pharmaceuticals, LLC
  • BBB Therapeutics B.V.
  • biOasis Technologies Inc.
  • Bionomics Limited
  • Bristol-Myers Squibb Company
  • Cavion LLC
  • Critical Outcome Technologies Inc.
  • CureFAKtor Pharmaceuticals, LLC
  • Diffusion Pharmaceuticals LLC
  • e-Therapeutics plc
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • GlaxoSmithKline plc
  • Hutchison MediPharma Limited
  • Merrimack Pharmaceuticals, Inc.
  • Nanobiotix
  • Nektar Therapeutics
  • Nerviano Medical Sciences S.r.l.
  • Neuralstem, Inc.
  • Novartis AG
  • Oncology Research International Limited
  • Pfizer Inc.
  • Philogen S.p.A.
  • Phosplatin Therapeutics
  • Prana Biotechnology Limited
  • Puma Biotechnology, Inc.
  • RadioRx, Inc.
  • Sagetis Biotech, S.L.

For more information visit http://www.researchandmarkets.com/research/z36pzl/brain_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology